I Fumagalli1, J-C Faivre2, S Thureau3, J-E Bibault4, O Diaz5, T Leroy4, B Pichon6, O Riou7, C Fournier8, J-M Hannoun-Lévi9, D Peiffert10. 1. Société française des jeunes radiothérapeutes oncologues (SFjRO), centre Antoine-Béclère, faculté de médecine, 45, rue des Saints-Pères, 75006 Paris, France; Département universitaire de radiothérapie-curiethérapie, centre Oscar-Lambret, 3, rue Frédéric-Combemale, BP 307, 59020 Lille cedex, France. Electronic address: fumagalli.ingrid@gmail.com. 2. Société française des jeunes radiothérapeutes oncologues (SFjRO), centre Antoine-Béclère, faculté de médecine, 45, rue des Saints-Pères, 75006 Paris, France; Département universitaire de radiothérapie-curiethérapie, institut de cancérologie de Lorraine (Alexis-Vautrin), 6, avenue de Bourgogne, CS30 519, 54511 Vandœuvre-lès-Nancy cedex, France. 3. Société française des jeunes radiothérapeutes oncologues (SFjRO), centre Antoine-Béclère, faculté de médecine, 45, rue des Saints-Pères, 75006 Paris, France; Département de radiothérapie et de physique médicale, QuantIf, Litis, centre Henri-Becquerel, rue d'Amiens, 76000 Rouen, France. 4. Société française des jeunes radiothérapeutes oncologues (SFjRO), centre Antoine-Béclère, faculté de médecine, 45, rue des Saints-Pères, 75006 Paris, France; Département universitaire de radiothérapie-curiethérapie, centre Oscar-Lambret, 3, rue Frédéric-Combemale, BP 307, 59020 Lille cedex, France. 5. Société française des jeunes radiothérapeutes oncologues (SFjRO), centre Antoine-Béclère, faculté de médecine, 45, rue des Saints-Pères, 75006 Paris, France; Service d'oncologie radiothérapie, centre hospitalier Lyon Sud, 165, chemin du Grand-Revoyet, 69495 Pierre-Bénite, France. 6. Société française des jeunes radiothérapeutes oncologues (SFjRO), centre Antoine-Béclère, faculté de médecine, 45, rue des Saints-Pères, 75006 Paris, France; Département d'oncologie radiothérapie, institut de cancérologie de l'Ouest René-Gauducheau, boulevard Jacques-Monod, 44805 Saint-Herblain, France. 7. Société française des jeunes radiothérapeutes oncologues (SFjRO), centre Antoine-Béclère, faculté de médecine, 45, rue des Saints-Pères, 75006 Paris, France; Département de radiothérapie, pôle d'oncologie radiothérapie, institut régional du cancer de Montpellier Val d'Aurelle - ICM, rue de la Croix-Verte, 34298 Montpellier cedex 5, France. 8. Département de biostastistiques, centre Oscar-Lambret, 3, rue Frédéric-Combemale, BP 307, 59020 Lille cedex, France. 9. Département de radiothérapie, centre Antoine-Lacassagne, université Nice-Sophia Antipolis, 33, avenue de Valombrose, 06000 Nice, France; Groupe de curiethérapie, Société française de radiothérapie oncologie (SFRO), centre Antoine-Béclère, faculté de médecine, 45, rue des Saints-Pères, 75006 Paris, France. 10. Département universitaire de radiothérapie-curiethérapie, institut de cancérologie de Lorraine (Alexis-Vautrin), 6, avenue de Bourgogne, CS30 519, 54511 Vandœuvre-lès-Nancy cedex, France; Groupe de curiethérapie, Société française de radiothérapie oncologie (SFRO), centre Antoine-Béclère, faculté de médecine, 45, rue des Saints-Pères, 75006 Paris, France.
Abstract
PURPOSE: The goal of this study was to evaluate the interest of the members of the French society of young radiation oncologists (SFjRO) for brachytherapy as well as their theoretical and practical level in this radiation technique. MATERIALS AND METHODS: An anonymous survey was conducted regarding practical and theoretical teaching of brachytherapy before the French national courses on brachytherapy. RESULTS: Among the 106 residents attending this teaching course, 99 (93%) answered the survey. Most of them were interested in brachytherapy but 82% considered they had not received sufficient teaching. Relevant indications of brachytherapy were known by 76% of the residents for gynaecological malignancies and 70% for prostate. Seventy-one percent of the residents have seen at least one gynecological brachytherapy but only 12% knew how to deal with this technique. Fifty-six percent have seen vaginal high dose rate brachytherapy and 21% had acquired the technique. For prostate brachytherapy, 65% had seen and done an implant and only 4% had acquired the technique. Fifty percent have performed at least one brachytherapy treatment during their residency. Residents expressed a strong wish for more courses about dosimetry (82%), technique (75%) and treatment planning (90%). CONCLUSION: Our study shows the interest of French residents for brachytherapy but suggests that practical teaching courses and an evaluation of the existing theoretical courses are warranted.
PURPOSE: The goal of this study was to evaluate the interest of the members of the French society of young radiation oncologists (SFjRO) for brachytherapy as well as their theoretical and practical level in this radiation technique. MATERIALS AND METHODS: An anonymous survey was conducted regarding practical and theoretical teaching of brachytherapy before the French national courses on brachytherapy. RESULTS: Among the 106 residents attending this teaching course, 99 (93%) answered the survey. Most of them were interested in brachytherapy but 82% considered they had not received sufficient teaching. Relevant indications of brachytherapy were known by 76% of the residents for gynaecological malignancies and 70% for prostate. Seventy-one percent of the residents have seen at least one gynecological brachytherapy but only 12% knew how to deal with this technique. Fifty-six percent have seen vaginal high dose rate brachytherapy and 21% had acquired the technique. For prostate brachytherapy, 65% had seen and done an implant and only 4% had acquired the technique. Fifty percent have performed at least one brachytherapy treatment during their residency. Residents expressed a strong wish for more courses about dosimetry (82%), technique (75%) and treatment planning (90%). CONCLUSION: Our study shows the interest of French residents for brachytherapy but suggests that practical teaching courses and an evaluation of the existing theoretical courses are warranted.
Authors: Jean-Christophe Faivre; Jean-Emmanuel Bibault; Thomas Leroy; Mikaël Agopiantz; Julia Salleron; Maxime Wack; Guillaume Janoray; Henri Roché; Stéphane Culine; Sofia Rivera Journal: J Cancer Educ Date: 2018-04 Impact factor: 2.037